Meropenem Noridem (Meropenem Anhydrous)

• Meropenem is a broad‑spectrum carbapenem antibiotic used for severe bacterial infections affecting various organ systems.
• Complicated intra‑abdominal infections: achieves bacterial eradication in severe abdominal sepsis.
• Complicated urinary tract infections: clears resistant Gram‑negative pathogens in the urinary system.
• Meningitis: penetrates the cerebrospinal fluid to treat central nervous system infections.
• Pneumonia: provides coverage against multidrug‑resistant respiratory pathogens.
• Sepsis: offers rapid bactericidal activity in systemic infections.

• Meropenem binds to penicillin‑binding proteins on bacterial cell walls, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its broad spectrum includes many Gram‑negative, Gram‑positive, and anaerobic organisms, and it resists most β‑lactamases.

Meropenem may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Nausea: mild to moderate gastrointestinal discomfort.
• Diarrhea: may be watery and self‑limiting.
• Rash: skin erythema or pruritus.
• Headache: transient and usually resolves.

Serious or Rare Side Effects

• Seizures: especially in patients with renal impairment or high doses.
• Clostridioides difficile infection: severe colitis risk.
• Anaphylaxis: acute hypersensitivity reaction.
• Severe neutropenia or thrombocytopenia: marked reduction in blood cell counts.

When using Meropenem, clinicians should consider several precautionary measures to ensure safe therapy.

• Renal function: adjust dosage in patients with impaired clearance.
• Hepatic function: monitor liver enzymes during prolonged therapy.
• Allergic reactions: avoid in individuals with known carbapenem hypersensitivity.
• Valproic acid co‑administration: may reduce serum levels of the anticonvulsant.
• Pregnancy and lactation: limited data; weigh maternal benefits against potential fetal risk.
• Store at below 25°C: keep in original packaging, protect from moisture and light.

Meropenem can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid)

• Valproic acid: reduces anticonvulsant levels, risking seizure breakthrough.
• Other carbapenems: concurrent use provides no added benefit and may increase toxicity.
• High‑dose aminoglycosides: heightened nephrotoxic potential.

Moderate Interactions (Monitor Closely)

• Loop diuretics: may exacerbate renal dysfunction.
• Warfarin: monitor INR as antibiotic effect can alter anticoagulation.
• NSAIDs: combined renal risk, especially in dehydrated patients.